News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>Jefferies Downgrades CSPC PHARMA (01093.HK) to Underperform, Adds TP to $5
CSPC PHARMA (01093.HK)'s share price soared 70% in total YTD (up more than 30% in the last 2 weeks alone), mainly driven by high expectations for its commercial development pot...
Reset
Send
The window will close in 5 seconds
<Research>Jefferies Downgrades CSPC PHARMA (01093.HK) to Underperform, Adds TP to $5
Close
Recommend
10
Positive
17
Negative
9
 
SHORT SELL
 
STOCK INFO

CSPC PHARMA (01093.HK)  -0.190 (-2.360%)    Short selling $314.50M; Ratio 18.300%   's share price soared 70% in total YTD (up more than 30% in the last 2 weeks alone), mainly driven by high expectations for its commercial development potential and hopes for a turning point in its earnings, according to a research report issued by Jefferies.

However, it seems that all of these positive factors are now being reflected in the share price performance.

Related NewsBOCOMI Lifts CSPC PHARMA (01093.HK) TP to $7.2, Keeps Rating at Neutral
Therefore, Jefferies downgraded CSPC PHARMA to Underperform from Hold to reflect its over-valuation at current price.

The broker remained optimistic that the Group is one of the most successful pharmaceutical companies in China, and revised its 2025-2027 revenue forecasts to RMB28.7 billion/ RMB27.6 billion/ RMB26.4 billion, and net profit forecasts to RMB4.1 billion/ RMB3.6 billion/ RMB3.1 billion. Jefferies added its target price to $5 from $4.6.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-06-05 16:25.)

AAStocks Financial News
Website: www.aastocks.com
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.